Blueberries Medical Corp (1OA) - Net Assets
Based on the latest financial reports, Blueberries Medical Corp (1OA) has net assets worth €942.86K EUR as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€1.34 Million) and total liabilities (€395.46K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €942.86K |
| % of Total Assets | 70.45% |
| Annual Growth Rate | N/A |
| 5-Year Change | -78.54% |
| 10-Year Change | N/A |
| Growth Volatility | 38.04 |
Blueberries Medical Corp - Net Assets Trend (2016–2024)
This chart illustrates how Blueberries Medical Corp's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Blueberries Medical Corp (2016–2024)
The table below shows the annual net assets of Blueberries Medical Corp from 2016 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €834.81K | -57.10% |
| 2023-12-31 | €1.95 Million | +32.58% |
| 2022-12-31 | €1.47 Million | +2.30% |
| 2021-12-31 | €1.43 Million | -63.11% |
| 2020-12-31 | €3.89 Million | -51.83% |
| 2019-12-31 | €8.08 Million | +11573.69% |
| 2017-12-31 | €-70.38K | +77.65% |
| 2016-12-31 | €-314.91K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Blueberries Medical Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 2455142800.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | €26.50 Million | 3174.03% |
| Total Equity | €834.81K | 100.00% |
Blueberries Medical Corp Competitors by Market Cap
The table below lists competitors of Blueberries Medical Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Tracsis Plc
LSE:TRCS
|
$1.16 Million |
|
CT UK High Income Ord
LSE:CHI
|
$1.16 Million |
|
Sobr Safe Inc
NASDAQ:SOBR
|
$1.16 Million |
|
TinOne Resources Inc
V:TORC
|
$1.16 Million |
|
Lucibel
PA:ALUCI
|
$1.15 Million |
|
Earthwise Minerals Corp.
F:966
|
$1.15 Million |
|
Trifast plc
LSE:TRI
|
$1.15 Million |
|
Gateley (Holdings) Plc
LSE:GTLY
|
$1.15 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Blueberries Medical Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,945,941 to 834,814, a change of -1,111,127 (-57.1%).
- Net loss of 1,148,533 reduced equity.
- Other factors increased equity by 37,406.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-1.15 Million | -137.58% |
| Other Changes | €37.41K | +4.48% |
| Total Change | €- | -57.10% |
Book Value vs Market Value Analysis
This analysis compares Blueberries Medical Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.96x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | €-0.14 | €0.00 | x |
| 2017-12-31 | €-0.01 | €0.00 | x |
| 2019-12-31 | €0.07 | €0.00 | x |
| 2020-12-31 | €0.03 | €0.00 | x |
| 2021-12-31 | €0.01 | €0.00 | x |
| 2022-12-31 | €0.01 | €0.00 | x |
| 2023-12-31 | €0.00 | €0.00 | x |
| 2024-12-31 | €0.00 | €0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Blueberries Medical Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -137.58%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -243.64%
- • Asset Turnover: 0.34x
- • Equity Multiplier: 1.65x
- Recent ROE (-137.58%) is below the historical average (-117.62%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 0.00% | 0.00% | 0.00x | 0.00x | €-384.44K |
| 2017 | 0.00% | 0.00% | 0.00x | 0.00x | €-8.43K |
| 2019 | -133.59% | -232297.07% | 0.00x | 1.21x | €-11.60 Million |
| 2020 | -127.00% | -7487.51% | 0.01x | 1.87x | €-5.33 Million |
| 2021 | -358.74% | -3709.64% | 0.04x | 2.50x | €-5.29 Million |
| 2022 | -100.01% | -623.44% | 0.07x | 2.29x | €-1.61 Million |
| 2023 | -84.04% | -567.30% | 0.12x | 1.24x | €-1.83 Million |
| 2024 | -137.58% | -243.64% | 0.34x | 1.65x | €-1.23 Million |
Industry Comparison
This section compares Blueberries Medical Corp's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $7,070,812,915
- Average return on equity (ROE) among peers: -280.54%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Blueberries Medical Corp (1OA) | €942.86K | 0.00% | 0.42x | $1.16 Million |
| 26U (26U) | $-312.00K | 0.00% | 0.00x | $128.79 Million |
| 27N0 (27N0) | $136.23K | -2327.02% | 2.00x | $566.23K |
| iAnthus Capital Holdings Inc (2IA) | $-103.04 Million | 0.00% | 0.00x | $4.08 Million |
| Revive Therapeutics Ltd (31R) | $7.43 Million | -72.44% | 0.11x | $397.77K |
| AYR WELLNESS INC.RES.VTG. (3KJB) | $570.65 Million | -47.74% | 1.56x | $5.84 Million |
| Vibe Growth Corporation (3ST) | $21.39 Million | -20.09% | 0.54x | $214.59K |
| AYURCANN HOLDINGS CORP. (3ZQ0) | $4.89 Million | -63.10% | 0.49x | $113.81K |
| LORDS CO. WORLDW. HOLD. (4XM) | $-1.01 Million | 0.00% | 0.00x | $134.78K |
| China Resources Pharmaceutical Group Limited (640) | $63.14 Billion | 5.52% | 1.55x | $4.42 Billion |
About Blueberries Medical Corp
Blueberries Medical Corp. engages in the growth, cultivation, and development of medicinal cannabis and related products in Colombia. The company produces psychoactive and non-psychoactive cannabis derivatives. It also distributes functional supplements, wellness products, and natural ingredients. Blueberries Medical Corp. is based in Vancouver, Canada.